Metabolic Syndrome and Breast Cancer Risk: Is There a Role for Metformin?
about
Src Inhibition Blocks c-Myc Translation and Glucose Metabolism to Prevent the Development of Breast Cancer.Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancersTumor mechanics and metabolic dysfunction.Diet-induced metabolic change induces estrogen-independent allometric mammary growthPriming cancer cells for drug resistance: role of the fibroblast niche.Metformin lowers the threshold for stress-induced senescence: a role for the microRNA-200 family and miR-205.
P2860
Metabolic Syndrome and Breast Cancer Risk: Is There a Role for Metformin?
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Metabolic Syndrome and Breast Cancer Risk: Is There a Role for Metformin?
@ast
Metabolic Syndrome and Breast Cancer Risk: Is There a Role for Metformin?
@en
type
label
Metabolic Syndrome and Breast Cancer Risk: Is There a Role for Metformin?
@ast
Metabolic Syndrome and Breast Cancer Risk: Is There a Role for Metformin?
@en
prefLabel
Metabolic Syndrome and Breast Cancer Risk: Is There a Role for Metformin?
@ast
Metabolic Syndrome and Breast Cancer Risk: Is There a Role for Metformin?
@en
P2093
P2860
P1476
Metabolic Syndrome and Breast Cancer Risk: Is There a Role for Metformin?
@en
P2093
Catherine Ibarra-Drendall
Eric C Dietze
Victoria L Seewaldt
P2860
P2888
P304
P356
10.1007/S12609-011-0050-8
P577
2011-07-13T00:00:00Z